IRCT20100123003140N15招募中2 期
The effect of oral Chromium picolinate supplementation on Liver Function, Oxidative Indicators, Leptin, Resisten, lipid profile, Blood Glucose Control Indicators, serum levels of Fetuin A and inflammatory factors in Non-Alcoholic Fatty Liver
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 50 years（—）
- 性别
- All
入选标准
- •Patients who agree to participate in the study
- •Men and women aged 20 to 50 years
- •BMI ranges from 25 to 40 kg / m 2
- •Increased levels of ALT and AST are higher than normal levels
- •Grade 2, 3, and 4 diseases
排除标准
- •kidney disease
- •Thyroid gland problems
- •Uncontrolled blood pressure
- •Taking statin
- •Hepatitis C and B
- •Cytomegalovirus
- •alcohol consumption
- •Hocromatosis
- •Deficiency of alpha-1 antitrypsin
研究者
相似试验
进行中（未招募）
不适用
Effect of supplementation of chromium in glucose of diabetic patientsC18.452.394.750.149Type 2 Diabetes MellitusRBR-79nxr8niversidade Feral do Rio Grande do Norte
已完成
2 期
Chromium Picolinate and ObesityObesity.Obesity, unspecifiedIRCT2014012210826N6Shahid Sadoughi University of Medical Science,International branch100
已完成
不适用
Chromium's Effect on Insulin Resistance in ObesityObesityInsulin ResistanceNCT00997659Stony Brook University40
招募中
3 期
Effect of the therapeutic effect of chromium supplementation with doses of 400 and 600 micrograms on body mass indexPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20210515051298N1Shahre-kord University of Medical Sciences120
已完成
3 期
Effect of chromium supplementation in treatment of patients with polycystic ovary syndrome candidate for IVFIRCT20170513033941N32Shahid Beheshti University of Medical Sciences40